SEQLL INC (SQL)

US81734C3043 - Common Stock

6.5991  -1.67 (-20.2%)

After market: 4.9999 -1.6 (-24.23%)

Fundamental Rating

2

SQL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. While SQL seems to be doing ok healthwise, there are quite some concerns on its profitability. SQL is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

SQL had negative earnings in the past year.
SQL had a negative operating cash flow in the past year.
SQL had negative earnings in each of the past 5 years.
SQL had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

SQL's Return On Assets of -79.09% is on the low side compared to the rest of the industry. SQL is outperformed by 91.80% of its industry peers.
SQL's Return On Equity of -181.20% is on the low side compared to the rest of the industry. SQL is outperformed by 90.16% of its industry peers.
Industry RankSector Rank
ROA -79.09%
ROE -181.2%
ROIC N/A
ROA(3y)-78.44%
ROA(5y)-151.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SQL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

SQL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SQL remains at a similar level compared to 1 year ago.
The number of shares outstanding for SQL has been reduced compared to 5 years ago.
SQL has a worse debt/assets ratio than last year.

2.2 Solvency

SQL has an Altman-Z score of -6.09. This is a bad value and indicates that SQL is not financially healthy and even has some risk of bankruptcy.
SQL has a Altman-Z score of -6.09. This is amonst the worse of the industry: SQL underperforms 91.80% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that SQL is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.50, SQL is not doing good in the industry: 73.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z -6.09
ROIC/WACCN/A
WACC11.75%

2.3 Liquidity

A Current Ratio of 5.04 indicates that SQL has no problem at all paying its short term obligations.
With a decent Current ratio value of 5.04, SQL is doing good in the industry, outperforming 70.49% of the companies in the same industry.
SQL has a Quick Ratio of 5.04. This indicates that SQL is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 5.04, SQL is doing good in the industry, outperforming 75.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.04
Quick Ratio 5.04

4

3. Growth

3.1 Past

SQL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3588.50%.
SQL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
Measured over the past years, SQL shows a very negative growth in Revenue. The Revenue has been decreasing by -43.28% on average per year.
EPS 1Y (TTM)-3588.5%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-4718.47%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-47.05%
Revenue growth 5Y-43.28%
Revenue growth Q2Q-100%

3.2 Future

SQL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.17% yearly.
The Revenue is expected to grow by 354.84% on average over the next years. This is a very strong growth
EPS Next Y96.95%
EPS Next 2Y39.64%
EPS Next 3Y25.17%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y354.84%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SQL. In the last year negative earnings were reported.
Also next year SQL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as SQL's earnings are expected to grow with 25.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.64%
EPS Next 3Y25.17%

0

5. Dividend

5.1 Amount

No dividends for SQL!.
Industry RankSector Rank
Dividend Yield N/A

SEQLL INC

NASDAQ:SQL (11/13/2023, 7:16:47 PM)

After market: 4.9999 -1.6 (-24.23%)

6.5991

-1.67 (-20.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.51M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -79.09%
ROE -181.2%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.04
Quick Ratio 5.04
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-3588.5%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y96.95%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-100%
Revenue growth 3Y-47.05%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y